Shayan Rab, MD
Associate Medical Director, Field-Based Services, Los Angeles County Department of Mental Health, Los Angeles, CA.
Dr. Rab has no financial relationships with companies related to this material.
Kyle T. Greenway, MD, MSc.
Assistant Professor of Psychiatry at McGill University. Director of the ketamine-assisted therapy program at Jewish General Hospital, Montreal, Canada.
Dr. Greenway has no financial relationships with companies related to this material.
David Mintz, MD.
Fellow, American Academy of Psychoanalysis and Dynamic Psychiatry. Staff psychiatrist, Austen Riggs Center, Stockbridge, MA.
Dr. Mintz has no financial relationships with companies related to this material.
Thanos Karatzias, PsyDip, MSc, PhD, CPsychol. Edinburgh Napier University, School of Health & Social Care, Edinburgh, Scotland.
Dr. Karatzias has no financial relationships with companies related to this material.
Mark L. Ruffalo, MSW, DPsa.
Editor-in-Chief, The Carlat Psychotherapy Report. Psychotherapist in private practice in Tampa, Florida. Assistant Professor of Psychiatry at the University of Central Florida College of Medicine and Adjunct Instructor of Psychiatry at Tufts University School of Medicine.
Dr. Ruffalo has no financial relationships with companies related to this material.
Awais Aftab, MD. Psychiatrist in Cleveland, Ohio, and Clinical Assistant Professor of Psychiatry at Case Western Reserve University. He writes an online newsletter, Psychiatry at the Margins. Twitter: @awaisaftab
Dr. Aftab has no financial relationships with companies related to this material.
Ilana Palgi, PsyD. Staff Psychologist, CL Medicine, New York, New York. Former Director, Center for Child Development, Queens Hospital Center Department of Pediatrics.
Dr. Palgi has no financial relationships with companies related to this material.
Dakota Carter, MD, EdD. Medical Director and Chair of Psychiatry, Eisenhower Behavioral Health, Eisenhower Health, Rancho Mirage, CA.
Dr. Carter has no financial relationships with companies related to this material.
Maureen C. Nash, MD.
Medical Director, Providence ElderPlace PACE Oregon. Co-editor, Neurocognitive Behavioral Disorders: An Interdisciplinary Approach to Patient-Centered Care (Springer; 2019). All comments are Dr. Nash’s personal views and not those of any organization.
Dr. Nash has no financial relationships with companies related to this material.
Paul S. Appelbaum, MD
Dollard Professor of Psychiatry, Medicine, & Law; Director, Center for Law, Ethics, and Psychiatry, Columbia University, New York, NY. Co-author of Assessing Competence to Consent to Treatment (Oxford University Press; 1998).
Dr. Appelbaum has no financial relationships with companies related to this material.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
RSS
